PRESCRIBING · PART D · 2024
Total Rx claims
172
Beneficiaries
—
Total drug cost
$658K
Distinct drugs
11
Brand share
66.3%
Top prescribed drugs
Bedaquiline Fumarate38 claims
Meropenem22 claims
Dalbavancin Hcl16 claims
Abacavir/Dolutegravir/Lamivudi13 claims
Omadacycline Tosylate12 claims
QUALITY · MIPS · 2024
Final MIPS score
84.9
Quality
73.6
Cost
76.1
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.42%
Group
CROSS-REFERENCE